Nishant Agrawal to Rhabdoid Tumor
This is a "connection" page, showing publications Nishant Agrawal has written about Rhabdoid Tumor.
Connection Strength
0.226
-
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors. Neuro Oncol. 2024 Oct 03; 26(10):1895-1911.
Score: 0.226